nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE3A—penis—skin cancer	0.122	0.387	CbGeAlD
Papaverine—PDE3B—connective tissue—skin cancer	0.037	0.117	CbGeAlD
Papaverine—PDE10A—head—skin cancer	0.0234	0.0741	CbGeAlD
Papaverine—PDE4B—nipple—skin cancer	0.023	0.0728	CbGeAlD
Papaverine—Decreased appetite—Vismodegib—skin cancer	0.0173	0.0303	CcSEcCtD
Papaverine—Constipation—Vismodegib—skin cancer	0.017	0.0298	CcSEcCtD
Papaverine—PDE10A—lymph node—skin cancer	0.0164	0.0519	CbGeAlD
Papaverine—PDE3A—female reproductive system—skin cancer	0.0159	0.0505	CbGeAlD
Papaverine—PDE3B—lymph node—skin cancer	0.0153	0.0484	CbGeAlD
Papaverine—Flushing—Imiquimod—skin cancer	0.0137	0.024	CcSEcCtD
Papaverine—Diarrhoea—Vismodegib—skin cancer	0.0136	0.0238	CcSEcCtD
Papaverine—PDE4B—mammalian vulva—skin cancer	0.0134	0.0425	CbGeAlD
Papaverine—Rash—Vismodegib—skin cancer	0.0126	0.0219	CcSEcCtD
Papaverine—Dermatitis—Vismodegib—skin cancer	0.0126	0.0219	CcSEcCtD
Papaverine—Ill-defined disorder—Imiquimod—skin cancer	0.0119	0.0209	CcSEcCtD
Papaverine—PDE4B—lymphoid tissue—skin cancer	0.0119	0.0377	CbGeAlD
Papaverine—Nausea—Vismodegib—skin cancer	0.0118	0.0207	CcSEcCtD
Papaverine—Blood pressure increased—Docetaxel—skin cancer	0.0117	0.0205	CcSEcCtD
Papaverine—Malaise—Imiquimod—skin cancer	0.0116	0.0203	CcSEcCtD
Papaverine—PDE4B—female reproductive system—skin cancer	0.0115	0.0364	CbGeAlD
Papaverine—Discomfort—Imiquimod—skin cancer	0.0108	0.0189	CcSEcCtD
Papaverine—Decreased appetite—Vemurafenib—skin cancer	0.0107	0.0187	CcSEcCtD
Papaverine—Constipation—Vemurafenib—skin cancer	0.0105	0.0184	CcSEcCtD
Papaverine—Anorexia—Imiquimod—skin cancer	0.01	0.0175	CcSEcCtD
Papaverine—Hepatitis—Dactinomycin—skin cancer	0.00979	0.0171	CcSEcCtD
Papaverine—Flushing—Bleomycin—skin cancer	0.00974	0.017	CcSEcCtD
Papaverine—PDE4B—head—skin cancer	0.0096	0.0304	CbGeAlD
Papaverine—PDE3A—lymph node—skin cancer	0.00933	0.0295	CbGeAlD
Papaverine—Decreased appetite—Imiquimod—skin cancer	0.00913	0.0159	CcSEcCtD
Papaverine—Flushing—Dactinomycin—skin cancer	0.00909	0.0159	CcSEcCtD
Papaverine—Hepatitis—Temozolomide—skin cancer	0.00886	0.0155	CcSEcCtD
Papaverine—Feeling abnormal—Imiquimod—skin cancer	0.00865	0.0151	CcSEcCtD
Papaverine—Ill-defined disorder—Bleomycin—skin cancer	0.00848	0.0148	CcSEcCtD
Papaverine—Diarrhoea—Vemurafenib—skin cancer	0.00842	0.0147	CcSEcCtD
Papaverine—Malaise—Bleomycin—skin cancer	0.00824	0.0144	CcSEcCtD
Papaverine—Flushing—Temozolomide—skin cancer	0.00822	0.0144	CcSEcCtD
Papaverine—Ill-defined disorder—Dactinomycin—skin cancer	0.00791	0.0138	CcSEcCtD
Papaverine—Rash—Vemurafenib—skin cancer	0.00776	0.0136	CcSEcCtD
Papaverine—Dermatitis—Vemurafenib—skin cancer	0.00775	0.0135	CcSEcCtD
Papaverine—Headache—Vemurafenib—skin cancer	0.00771	0.0135	CcSEcCtD
Papaverine—Discomfort—Bleomycin—skin cancer	0.00769	0.0134	CcSEcCtD
Papaverine—Malaise—Dactinomycin—skin cancer	0.00769	0.0134	CcSEcCtD
Papaverine—Nausea—Vemurafenib—skin cancer	0.00731	0.0128	CcSEcCtD
Papaverine—Diarrhoea—Imiquimod—skin cancer	0.00718	0.0125	CcSEcCtD
Papaverine—Discomfort—Dactinomycin—skin cancer	0.00717	0.0125	CcSEcCtD
Papaverine—Ill-defined disorder—Temozolomide—skin cancer	0.00715	0.0125	CcSEcCtD
Papaverine—Anorexia—Bleomycin—skin cancer	0.00711	0.0124	CcSEcCtD
Papaverine—Malaise—Temozolomide—skin cancer	0.00695	0.0121	CcSEcCtD
Papaverine—Vertigo—Temozolomide—skin cancer	0.00693	0.0121	CcSEcCtD
Papaverine—PDE4B—lymph node—skin cancer	0.00672	0.0213	CbGeAlD
Papaverine—Anorexia—Dactinomycin—skin cancer	0.00663	0.0116	CcSEcCtD
Papaverine—Rash—Imiquimod—skin cancer	0.00662	0.0116	CcSEcCtD
Papaverine—Dermatitis—Imiquimod—skin cancer	0.00661	0.0116	CcSEcCtD
Papaverine—PDE10A—G alpha (s) signalling events—MC1R—skin cancer	0.00661	0.0591	CbGpPWpGaD
Papaverine—Headache—Imiquimod—skin cancer	0.00658	0.0115	CcSEcCtD
Papaverine—Discomfort—Temozolomide—skin cancer	0.00648	0.0113	CcSEcCtD
Papaverine—Decreased appetite—Bleomycin—skin cancer	0.00648	0.0113	CcSEcCtD
Papaverine—Nausea—Imiquimod—skin cancer	0.00624	0.0109	CcSEcCtD
Papaverine—Feeling abnormal—Bleomycin—skin cancer	0.00615	0.0107	CcSEcCtD
Papaverine—Decreased appetite—Dactinomycin—skin cancer	0.00605	0.0106	CcSEcCtD
Papaverine—Anorexia—Temozolomide—skin cancer	0.006	0.0105	CcSEcCtD
Papaverine—Discomfort—Fluorouracil—skin cancer	0.00597	0.0104	CcSEcCtD
Papaverine—Hepatitis—Docetaxel—skin cancer	0.00589	0.0103	CcSEcCtD
Papaverine—Feeling abnormal—Dactinomycin—skin cancer	0.00573	0.01	CcSEcCtD
Papaverine—Anorexia—Fluorouracil—skin cancer	0.00553	0.00965	CcSEcCtD
Papaverine—Decreased appetite—Temozolomide—skin cancer	0.00547	0.00955	CcSEcCtD
Papaverine—Flushing—Docetaxel—skin cancer	0.00547	0.00955	CcSEcCtD
Papaverine—Constipation—Temozolomide—skin cancer	0.00538	0.0094	CcSEcCtD
Papaverine—Feeling abnormal—Temozolomide—skin cancer	0.00518	0.00906	CcSEcCtD
Papaverine—Decreased appetite—Fluorouracil—skin cancer	0.00504	0.0088	CcSEcCtD
Papaverine—Feeling abnormal—Fluorouracil—skin cancer	0.00478	0.00835	CcSEcCtD
Papaverine—Diarrhoea—Dactinomycin—skin cancer	0.00476	0.00831	CcSEcCtD
Papaverine—Rash—Bleomycin—skin cancer	0.0047	0.00822	CcSEcCtD
Papaverine—Dermatitis—Bleomycin—skin cancer	0.0047	0.00821	CcSEcCtD
Papaverine—Nausea—Bleomycin—skin cancer	0.00443	0.00774	CcSEcCtD
Papaverine—Rash—Dactinomycin—skin cancer	0.00439	0.00766	CcSEcCtD
Papaverine—PDE10A—G alpha (s) signalling events—PTGER4—skin cancer	0.00434	0.0389	CbGpPWpGaD
Papaverine—Diarrhoea—Temozolomide—skin cancer	0.0043	0.00752	CcSEcCtD
Papaverine—PDE3B—G alpha (s) signalling events—MC1R—skin cancer	0.00427	0.0382	CbGpPWpGaD
Papaverine—Nausea—Dactinomycin—skin cancer	0.00413	0.00722	CcSEcCtD
Papaverine—Anorexia—Docetaxel—skin cancer	0.00399	0.00697	CcSEcCtD
Papaverine—Rash—Temozolomide—skin cancer	0.00397	0.00693	CcSEcCtD
Papaverine—Diarrhoea—Fluorouracil—skin cancer	0.00397	0.00693	CcSEcCtD
Papaverine—Dermatitis—Temozolomide—skin cancer	0.00396	0.00692	CcSEcCtD
Papaverine—Headache—Temozolomide—skin cancer	0.00394	0.00689	CcSEcCtD
Papaverine—PDE3A—G alpha (s) signalling events—MC1R—skin cancer	0.00389	0.0348	CbGpPWpGaD
Papaverine—Nausea—Temozolomide—skin cancer	0.00374	0.00653	CcSEcCtD
Papaverine—PDE4B—G alpha (s) signalling events—MC1R—skin cancer	0.0037	0.0331	CbGpPWpGaD
Papaverine—Rash—Fluorouracil—skin cancer	0.00365	0.00639	CcSEcCtD
Papaverine—Dermatitis—Fluorouracil—skin cancer	0.00365	0.00638	CcSEcCtD
Papaverine—Decreased appetite—Docetaxel—skin cancer	0.00364	0.00635	CcSEcCtD
Papaverine—Headache—Fluorouracil—skin cancer	0.00363	0.00634	CcSEcCtD
Papaverine—Constipation—Docetaxel—skin cancer	0.00358	0.00625	CcSEcCtD
Papaverine—Feeling abnormal—Docetaxel—skin cancer	0.00345	0.00602	CcSEcCtD
Papaverine—Nausea—Fluorouracil—skin cancer	0.00344	0.00602	CcSEcCtD
Papaverine—Diarrhoea—Docetaxel—skin cancer	0.00286	0.005	CcSEcCtD
Papaverine—PDE3B—G alpha (s) signalling events—PTGER4—skin cancer	0.00281	0.0251	CbGpPWpGaD
Papaverine—Rash—Docetaxel—skin cancer	0.00264	0.00461	CcSEcCtD
Papaverine—Dermatitis—Docetaxel—skin cancer	0.00264	0.0046	CcSEcCtD
Papaverine—Headache—Docetaxel—skin cancer	0.00262	0.00458	CcSEcCtD
Papaverine—PDE3A—G alpha (s) signalling events—PTGER4—skin cancer	0.00256	0.0229	CbGpPWpGaD
Papaverine—Nausea—Docetaxel—skin cancer	0.00249	0.00434	CcSEcCtD
Papaverine—PDE4B—G alpha (s) signalling events—PTGER4—skin cancer	0.00243	0.0218	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RHOU—skin cancer	0.00206	0.0184	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PTCH2—skin cancer	0.0017	0.0152	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—MC1R—skin cancer	0.00136	0.0121	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RHOU—skin cancer	0.00133	0.0119	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—MC1R—skin cancer	0.00123	0.011	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RHOU—skin cancer	0.00121	0.0109	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RHOU—skin cancer	0.00115	0.0103	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—NRAS—skin cancer	0.00112	0.00999	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PTCH2—skin cancer	0.0011	0.00985	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—NRAS—skin cancer	0.00109	0.00971	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—NRAS—skin cancer	0.00108	0.00963	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—NRAS—skin cancer	0.00105	0.00937	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—NRAS—skin cancer	0.00105	0.00937	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTCH2—skin cancer	0.00101	0.009	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PTCH2—skin cancer	0.001	0.00897	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—KRAS—skin cancer	0.000961	0.0086	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PTCH2—skin cancer	0.000954	0.00854	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—KRAS—skin cancer	0.000935	0.00836	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—KRAS—skin cancer	0.000926	0.00829	CbGpPWpGaD
Papaverine—PDE3B—Leptin signaling pathway—HRAS—skin cancer	0.000903	0.00808	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—KRAS—skin cancer	0.000902	0.00807	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—KRAS—skin cancer	0.000902	0.00807	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—NRAS—skin cancer	0.0009	0.00805	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—PTGER4—skin cancer	0.000891	0.00797	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—MC1R—skin cancer	0.000877	0.00785	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—SHH—skin cancer	0.000877	0.00784	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—NRAS—skin cancer	0.000871	0.00779	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—SMO—skin cancer	0.000831	0.00744	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PTCH1—skin cancer	0.000831	0.00744	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—HRAS—skin cancer	0.000817	0.00731	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PTGER4—skin cancer	0.000809	0.00724	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—MC1R—skin cancer	0.000799	0.00715	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—MC1R—skin cancer	0.000796	0.00712	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—HRAS—skin cancer	0.000794	0.00711	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—HRAS—skin cancer	0.000787	0.00704	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—IL6—skin cancer	0.000782	0.00699	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—KRAS—skin cancer	0.000775	0.00693	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—HRAS—skin cancer	0.000767	0.00686	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—HRAS—skin cancer	0.000767	0.00686	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—GLI2—skin cancer	0.000762	0.00682	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—IL6—skin cancer	0.00076	0.0068	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—MC1R—skin cancer	0.00076	0.0068	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—IL6—skin cancer	0.000753	0.00674	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—KRAS—skin cancer	0.000749	0.0067	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—IL6—skin cancer	0.000734	0.00656	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—IL6—skin cancer	0.000734	0.00656	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MC1R—skin cancer	0.000727	0.0065	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MC1R—skin cancer	0.000725	0.00649	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—GLI1—skin cancer	0.000716	0.00641	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MC1R—skin cancer	0.00069	0.00617	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SUFU—skin cancer	0.000679	0.00608	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—HRAS—skin cancer	0.000658	0.00589	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTCH2—skin cancer	0.000651	0.00582	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—HRAS—skin cancer	0.000637	0.0057	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—IL6—skin cancer	0.00061	0.00545	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTCH2—skin cancer	0.000593	0.0053	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PTGER4—skin cancer	0.000577	0.00516	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—SHH—skin cancer	0.000567	0.00508	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTCH2—skin cancer	0.000564	0.00504	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PTCH1—skin cancer	0.000538	0.00481	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—SMO—skin cancer	0.000538	0.00481	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PTGER4—skin cancer	0.000525	0.0047	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PTGER4—skin cancer	0.000524	0.00468	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SHH—skin cancer	0.000518	0.00463	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—SHH—skin cancer	0.000517	0.00462	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RASA1—skin cancer	0.000515	0.00461	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PTGER4—skin cancer	0.0005	0.00447	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GLI2—skin cancer	0.000493	0.00441	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—SHH—skin cancer	0.000492	0.0044	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SMO—skin cancer	0.000491	0.00439	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTCH1—skin cancer	0.000491	0.00439	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—SMO—skin cancer	0.00049	0.00438	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PTCH1—skin cancer	0.00049	0.00438	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTGER4—skin cancer	0.000478	0.00428	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PTGER4—skin cancer	0.000477	0.00427	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MC1R—skin cancer	0.00047	0.00421	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PTCH1—skin cancer	0.000466	0.00417	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—SMO—skin cancer	0.000466	0.00417	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GLI1—skin cancer	0.000464	0.00415	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PTGER4—skin cancer	0.000454	0.00406	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GLI2—skin cancer	0.000449	0.00402	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SUFU—skin cancer	0.00044	0.00393	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MC1R—skin cancer	0.000428	0.00383	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GLI2—skin cancer	0.000427	0.00382	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—FOXO4—skin cancer	0.000422	0.00378	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GLI1—skin cancer	0.000422	0.00378	CbGpPWpGaD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000419	0.00375	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—NRAS—skin cancer	0.000414	0.0037	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MC1R—skin cancer	0.000408	0.00365	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GLI1—skin cancer	0.000402	0.00359	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SUFU—skin cancer	0.0004	0.00358	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SUFU—skin cancer	0.000381	0.00341	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—KRAS—skin cancer	0.000356	0.00319	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SHH—skin cancer	0.000335	0.003	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RASA1—skin cancer	0.000333	0.00298	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTCH1—skin cancer	0.000318	0.00284	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SMO—skin cancer	0.000318	0.00284	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—TP53—skin cancer	0.000317	0.00283	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTGER4—skin cancer	0.000309	0.00277	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SHH—skin cancer	0.000305	0.00273	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RASA1—skin cancer	0.000303	0.00271	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—HRAS—skin cancer	0.000303	0.00271	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SHH—skin cancer	0.00029	0.0026	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTCH1—skin cancer	0.000289	0.00259	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SMO—skin cancer	0.000289	0.00259	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RASA1—skin cancer	0.000289	0.00258	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TERT—skin cancer	0.000282	0.00252	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTGER4—skin cancer	0.000282	0.00252	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTCH1—skin cancer	0.000275	0.00246	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SMO—skin cancer	0.000275	0.00246	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FOXO4—skin cancer	0.000273	0.00244	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTGER4—skin cancer	0.000268	0.0024	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—NRAS—skin cancer	0.000268	0.0024	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FOXO4—skin cancer	0.000249	0.00223	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—NRAS—skin cancer	0.000244	0.00218	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—NRAS—skin cancer	0.000238	0.00213	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FOXO4—skin cancer	0.000237	0.00212	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—KRAS—skin cancer	0.000231	0.00206	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—BRAF—skin cancer	0.000223	0.002	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—KRAS—skin cancer	0.00021	0.00188	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TP53—skin cancer	0.000205	0.00183	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—KRAS—skin cancer	0.000205	0.00183	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HRAS—skin cancer	0.000196	0.00175	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—skin cancer	0.000187	0.00167	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TERT—skin cancer	0.000183	0.00163	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—skin cancer	0.000179	0.0016	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—skin cancer	0.000174	0.00156	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—skin cancer	0.000166	0.00149	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TERT—skin cancer	0.000166	0.00149	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TERT—skin cancer	0.000158	0.00141	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NRAS—skin cancer	0.000154	0.00138	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BRAF—skin cancer	0.000145	0.00129	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NRAS—skin cancer	0.00014	0.00126	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NRAS—skin cancer	0.00014	0.00125	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NRAS—skin cancer	0.000133	0.00119	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—skin cancer	0.000132	0.00118	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BRAF—skin cancer	0.000132	0.00118	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BRAF—skin cancer	0.000125	0.00112	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—skin cancer	0.000121	0.00108	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—skin cancer	0.000121	0.00108	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—skin cancer	0.000115	0.00103	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—skin cancer	0.000112	0.00101	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—skin cancer	0.000108	0.000963	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—skin cancer	0.000107	0.000961	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—skin cancer	0.000103	0.000919	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—skin cancer	0.000102	0.000917	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—skin cancer	9.83e-05	0.000879	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—skin cancer	9.81e-05	0.000877	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—skin cancer	9.75e-05	0.000872	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—skin cancer	9.33e-05	0.000834	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NRAS—skin cancer	9.08e-05	0.000813	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRAS—skin cancer	8.27e-05	0.00074	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRAS—skin cancer	7.87e-05	0.000704	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—skin cancer	7.82e-05	0.000699	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—skin cancer	7.12e-05	0.000637	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—skin cancer	6.95e-05	0.000622	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—skin cancer	6.77e-05	0.000606	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—skin cancer	6.65e-05	0.000595	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—skin cancer	6.36e-05	0.000569	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—skin cancer	6.33e-05	0.000566	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—skin cancer	6.05e-05	0.000541	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—skin cancer	6.02e-05	0.000539	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—skin cancer	5.79e-05	0.000518	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—skin cancer	5.76e-05	0.000515	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—skin cancer	5.51e-05	0.000493	CbGpPWpGaD
